However, a direct effect of semaglutide could not be ruled out
The 2025 ACG abstract by Park et al
doi:10.1371/journal.pone.0103982 Chiang KC, Sun CC, Chen MH, Huang CY, Hsu JT, Yeh TS, Chen LW, Kuo SF, Juang HH, Takano M et al (2016) MART-10, the new brand of 1alpha,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro
amazon.com/s?k=blate+papes&
The FDA concluded that Novo Nordisk successfully demonstrated that its supply currently meets or exceeds the demand for its semaglutide injection products, and Novo Nordisk has developed sufficient reserves such that supply will meet or exceed projected future demands
Some patients see improvements within weeks, although full benefits may take longer depending on individual response